$ 10.81
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
In Guru Portfolios
Manager | Fund | Portfolio Weight (%) | Change |
|---|---|---|---|
| Kenneth Griffin | CITADEL ADVISORS LLC | 0.0% | +0.00% |
About
Oaktree Acquisition Corp. III Life Sciences operates as a special purpose acquisition company (SPAC). Its primary objective is to execute a strategic business combination—such as a merger, an exchange of capital stock, an asset or stock acquisition, or a broader corporate restructuring—with one or more existing enterprises. Established in 1995, this company maintains its principal office in Los Angeles, California.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.
Data is available to registered users only